4-(4-(E)-(propen-1-yl)phenylamino)-6-fluoro-7-(4-(2-methoxyethyl)piperazin-1-yl)quinazoline

ID: ALA4550134

PubChem CID: 155550298

Max Phase: Preclinical

Molecular Formula: C24H28FN5O

Molecular Weight: 421.52

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C/C=C/c1ccc(Nc2ncnc3cc(N4CCN(CCOC)CC4)c(F)cc23)cc1

Standard InChI:  InChI=1S/C24H28FN5O/c1-3-4-18-5-7-19(8-6-18)28-24-20-15-21(25)23(16-22(20)26-17-27-24)30-11-9-29(10-12-30)13-14-31-2/h3-8,15-17H,9-14H2,1-2H3,(H,26,27,28)/b4-3+

Standard InChI Key:  SZFTZXSLNGKFBT-ONEGZZNKSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   30.5483  -21.2800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5472  -22.0995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2552  -22.5085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2534  -20.8711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9621  -21.2764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9628  -22.0954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6714  -22.5024    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.3796  -22.0916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3749  -21.2695    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.6658  -20.8661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8405  -20.8715    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   32.6614  -20.0489    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.3670  -19.6366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0723  -20.0448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7773  -19.6332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7734  -18.8151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0586  -18.4105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3565  -18.8244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8427  -22.5053    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.1355  -22.0939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4295  -22.4985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4247  -23.3160    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.1319  -23.7273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8440  -23.3211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4784  -18.4018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1888  -18.8057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8938  -18.3924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7151  -23.7214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0093  -23.3095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2997  -23.7149    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.5939  -23.3031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  1 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 19 20  1  0
 19 24  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
  2 19  1  0
 16 25  1  0
 25 26  2  0
 26 27  1  0
 22 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4550134

    ---

Associated Targets(Human)

SW480 (6023 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-431 (6446 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1975 (4994 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC827 (1172 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 421.52Molecular Weight (Monoisotopic): 421.2278AlogP: 4.31#Rotatable Bonds: 7
Polar Surface Area: 53.52Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.03CX LogP: 4.63CX LogD: 4.48
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.61Np Likeness Score: -1.29

References

1. Zhang Y, Hou Q, Li X, Zhu J, Wang W, Li B, Zhao L, Xia H..  (2019)  Enrichment of novel quinazoline derivatives with high antitumor activity in mitochondria tracked by its self-fluorescence.,  178  [PMID:31202990] [10.1016/j.ejmech.2019.06.015]

Source